Tech Company Financing Transactions
NxThera Funding Round
NxThera, based in Maple Grove, secured investment capital from private investors.
Transaction Overview
Company Name
Announced On
2/27/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Proceeds Purpose
This Series C financing is being used to fund NxThera's (i) Rezum® U.S. pivotal clinical trial, the data from which will be used to seek FDA clearance to market its Rezum System to treat benign prostatic hyperplasia (BPH), (ii) commercialization of its Rezum System to treat BPH at select centers in Europe, and (iii) clinical feasibility studies to evaluate applications of Convective WAVE Technology to treat prostate cancer and kidney cancer.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Lane N 138
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 2/27/2014: If You Can venture capital transaction
Next: 2/27/2014: Respiratory Motion venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs